immunology

Summer temperatures, humidity and allergies are triggers for people diagnosed with asthma. These triggers can range from being a nuisance to being life-threatening.Dr. Jacqueline Squire, [...]

ROCHESTER, Minn. — Mayo Clinic experts say, regardless of the variant, prevention of infection works. The vaccines reduce and prevent hospitalization and death based on [...]

Some people are at higher risk of getting very sick from COVID-19 because of their age or underlying health conditions, according to the Centers for [...]

ROCHESTER, Minn. — Mesenchymal stromal cells from fat tissue and bone marrow are widely used in therapeutic trials for their anti-inflammatory qualities, but new Mayo [...]

ROCHESTER, Minn. — An enzyme intended to prevent autoimmune disease can be hijacked and used by some viruses to avoid immune detection. That discovery [...]

Spring is officially here and, depending on where you live, many Americans are already officially sniffling with seasonal allergies. An estimated 30 percent of adults [...]

ROCHESTER, Minn. — Research from Mayo Clinic included in the November issue of JAMA Neurology identifies a new biomarker for brain and spinal cord inflammation, allowing for faster [...]

Patients with metastatic bladder cancer have few treatment options after failure of chemotherapy until now. In early May, the U.S. Food and Drug Administration [...]

Former President Jimmy Carter made news around the world a few months ago when, after a battle with potentially deadly melanoma, he revealed he was [...]

Great medical care often involves integrative collaborations among several specialties – teams of doctors working together. The patient is a vital member of that team, [...]

https://www.youtube.com/watch?v=zFc1B91j9WY   JACKSONVILLE, Fla. — Researchers on Mayo Clinic’s Florida campus have been awarded a $13.3 million, five-year federal grant to test a vaccine designed to prevent the recurrence of triple-negative breast cancer, a subset of breast cancer for which there are no targeted therapies. The clinical trial, which will enroll 280 patients at multiple clinical sites, is expected to begin early in 2016. The grant, the Breakthrough Award from the U.S. Department of Defense’s Breast Cancer Research Program, will fund a national, phase II clinical trial testing the ability of a folate receptor alpha vaccine to prevent recurrence of this aggressive cancer following initial treatment. Journalists: Sound bites with Dr. Knutson are available in the downloads. MEDIA CONTACT: Kevin Punsky, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu

"Children with food allergies and asthma have a higher risk of a severe allergic reaction to the food allergy, than does a child without asthma," [...]